Lupus clinical trials at UC Irvine

1 research study open to eligible people

Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus
open to eligible people ages 18-75
The primary objective is to evaluate the efficacy and safety of efavaleukin alfa in subjects with active systemic lupus erythematosus.
Orange, California and other locations

Last updated: March 15, 2023